306 related articles for article (PubMed ID: 33495765)
1. High incidence of Epstein-Barr virus, cytomegalovirus, and human-herpes virus-6 reactivations in critically ill patients with COVID-19.
Simonnet A; Engelmann I; Moreau AS; Garcia B; Six S; El Kalioubie A; Robriquet L; Hober D; Jourdain M
Infect Dis Now; 2021 May; 51(3):296-299. PubMed ID: 33495765
[TBL] [Abstract][Full Text] [Related]
2. Reactivation of EBV and CMV in Severe COVID-19-Epiphenomena or Trigger of Hyperinflammation in Need of Treatment? A Large Case Series of Critically ill Patients.
Naendrup JH; Garcia Borrega J; Eichenauer DA; Shimabukuro-Vornhagen A; Kochanek M; Böll B
J Intensive Care Med; 2022 Sep; 37(9):1152-1158. PubMed ID: 34791940
[TBL] [Abstract][Full Text] [Related]
3. Epstein-Barr virus reactivation in critically ill immunocompetent patients.
Libert N; Bigaillon C; Chargari C; Bensalah M; Muller V; Merat S; de Rudnicki S
Biomed J; 2015; 38(1):70-6. PubMed ID: 25179711
[TBL] [Abstract][Full Text] [Related]
4. Reactivations of cytomegalovirus, human herpes virus 6, and Epstein-Barr virus differ with respect to risk factors and clinical outcome after hematopoietic stem cell transplantation.
Jaskula E; Dlubek D; Sedzimirska M; Duda D; Tarnowska A; Lange A
Transplant Proc; 2010 Oct; 42(8):3273-6. PubMed ID: 20970670
[TBL] [Abstract][Full Text] [Related]
5. Reactivation of herpesviruses during COVID-19: A systematic review and meta-analysis.
Shafiee A; Teymouri Athar MM; Amini MJ; Hajishah H; Siahvoshi S; Jalali M; Jahanbakhshi B; Mozhgani SH
Rev Med Virol; 2023 May; 33(3):e2437. PubMed ID: 36880642
[TBL] [Abstract][Full Text] [Related]
6. Epstein-Barr virus, Cytomegalovirus, and Herpes Simplex-1/2 reactivations in critically ill patients with COVID-19.
Mattei A; Schiavoni L; Riva E; Ciccozzi M; Veralli R; Urselli A; Citriniti V; Nenna A; Pascarella G; Costa F; Cataldo R; Agrò FE; Carassiti M
Intensive Care Med Exp; 2024 Apr; 12(1):40. PubMed ID: 38649512
[TBL] [Abstract][Full Text] [Related]
7. Cytomegalovirus reactivation in a general, nonimmunosuppressed intensive care unit population: incidence, risk factors, associations with organ dysfunction, and inflammatory biomarkers.
Frantzeskaki FG; Karampi ES; Kottaridi C; Alepaki M; Routsi C; Tzanela M; Vassiliadi DA; Douka E; Tsaousi S; Gennimata V; Ilias I; Nikitas N; Armaganidis A; Karakitsos P; Papaevangelou V; Dimopoulou I
J Crit Care; 2015 Apr; 30(2):276-81. PubMed ID: 25457114
[TBL] [Abstract][Full Text] [Related]
8. Differential Reactivation of Cytomegalovirus and Epstein-Barr Virus in Patients with B Cell Lymphoma.
Hatayama Y; Watanabe K; Ichikawa H; Kawamura K; Fukuda T; Motokura T
Viral Immunol; 2023 Oct; 36(8):520-525. PubMed ID: 37440168
[TBL] [Abstract][Full Text] [Related]
9. Cytomegalovirus and Epstein-Barr virus reactivation in the intensive care unit.
Coşkun O; Yazici E; Şahiner F; Karakaş A; Kiliç S; Tekin M; Artuk C; Yamanel L; Beşirbellioğlu BA
Med Klin Intensivmed Notfmed; 2017 Apr; 112(3):239-245. PubMed ID: 27435067
[TBL] [Abstract][Full Text] [Related]
10. Co-Reactivation of Cytomegalovirus and Epstein-Barr Virus Was Associated With Poor Prognosis After Allogeneic Stem Cell Transplantation.
Zhou JR; Shi DY; Wei R; Wang Y; Yan CH; Zhang XH; Xu LP; Liu KY; Huang XJ; Sun YQ
Front Immunol; 2020; 11():620891. PubMed ID: 33664733
[TBL] [Abstract][Full Text] [Related]
11. [How to manage EBV reactivation and EBV-PTLD, CMV and human herpesvirus 6 reactivation and infection after allogeneic stem cell transplantation: A report of the SFGM-TC (update)].
Brissot E; Alsuliman T; Gruson B; Hermet E; Tirefort Y; Yakoub-Agha I; Alain S
Bull Cancer; 2017 Dec; 104(12S):S181-S187. PubMed ID: 29169653
[TBL] [Abstract][Full Text] [Related]
12. Reactivation of multiple viruses in patients with sepsis.
Walton AH; Muenzer JT; Rasche D; Boomer JS; Sato B; Brownstein BH; Pachot A; Brooks TL; Deych E; Shannon WD; Green JM; Storch GA; Hotchkiss RS
PLoS One; 2014; 9(2):e98819. PubMed ID: 24919177
[TBL] [Abstract][Full Text] [Related]
13. Reactivation of human herpesvirus (HHV) family members other than HHV-6 in drug-induced hypersensitivity syndrome.
Seishima M; Yamanaka S; Fujisawa T; Tohyama M; Hashimoto K
Br J Dermatol; 2006 Aug; 155(2):344-9. PubMed ID: 16882173
[TBL] [Abstract][Full Text] [Related]
14. Reactivation of Epstein-Barr virus among intensive care patients: a prospective observational study.
Guiouillier F; Derely J; Salvadori A; Pochard J; Le Goff J; Martinez T; Raffin F; Laitselart P; Beaucreux C; Priou S; Conan PL; Foissaud V; Servonnet A; Vest P; Boutonnet M; de Rudnicki S; Bigaillon C; Libert N
Intensive Care Med; 2024 Mar; 50(3):418-426. PubMed ID: 38436725
[TBL] [Abstract][Full Text] [Related]
15. Epstein-Barr Virus and Human Herpesvirus-6 Reactivation in Acute COVID-19 Patients.
Brooks B; Tancredi C; Song Y; Mogus AT; Huang MW; Zhu H; Phan TL; Zhu H; Kadl A; Woodfolk J; Jerome KR; Zeichner SL
Viruses; 2022 Aug; 14(9):. PubMed ID: 36146679
[TBL] [Abstract][Full Text] [Related]
16. High intrahepatic HHV-6 virus loads but neither CMV nor EBV are associated with decreased graft survival after diagnosis of graft hepatitis.
Pischke S; Gösling J; Engelmann I; Schlue J; Wölk B; Jäckel E; Meyer-Heithuis C; Lehmann U; Strassburg CP; Barg-Hock H; Becker T; Manns MP; Schulz T; Wedemeyer H; Heim A
J Hepatol; 2012 May; 56(5):1063-1069. PubMed ID: 22245897
[TBL] [Abstract][Full Text] [Related]
17. Herpes DNAemia and TTV Viraemia in Intensive Care Unit Critically Ill Patients: A Single-Centre Prospective Longitudinal Study.
Mallet F; Diouf L; Meunier B; Perret M; Reynier F; Leissner P; Quemeneur L; Griffiths AD; Moucadel V; Pachot A; Venet F; Monneret G; Lepape A; Rimmelé T; Tan LK; Brengel-Pesce K; Textoris J
Front Immunol; 2021; 12():698808. PubMed ID: 34795661
[TBL] [Abstract][Full Text] [Related]
18. Epstein-Barr virus and cytomegalovirus reactivation after allogeneic hematopoietic cell transplantation in patients with non-Hodgkin lymphoma: the prevalence and impacts on outcomes : EBV and CMV reactivation post allo-HCT in NHL.
Ding Y; Ru Y; Song T; Guo L; Zhang X; Zhu J; Li C; Jin Z; Huang H; Tu Y; Xu M; Xu Y; Chen J; Wu D
Ann Hematol; 2021 Nov; 100(11):2773-2785. PubMed ID: 34480615
[TBL] [Abstract][Full Text] [Related]
19. Cytomegalovirus blood reactivation in COVID-19 critically ill patients: risk factors and impact on mortality.
Gatto I; Biagioni E; Coloretti I; Farinelli C; Avoni C; Caciagli V; Busani S; Sarti M; Pecorari M; Gennari W; Guaraldi G; Franceschini E; Meschiari M; Mussini C; Tonelli R; Clini E; Cossarizza A; Girardis M;
Intensive Care Med; 2022 Jun; 48(6):706-713. PubMed ID: 35583676
[TBL] [Abstract][Full Text] [Related]
20. Viral reactivations following hematopoietic stem cell transplantation in pediatric patients - A single center 11-year analysis.
Düver F; Weißbrich B; Eyrich M; Wölfl M; Schlegel PG; Wiegering V
PLoS One; 2020; 15(2):e0228451. PubMed ID: 32017805
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
